Skip to main content
Equibles

Coastal Bridge Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1665976 WESTPORT, CT
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,006,393
-$168,792 QoQ
Shares Held
1,614
+6.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#644
of 1,329 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Coastal Bridge Advisors, LLC holds $11,640,553 across 14 Biotechnology names. REGN ranks #6 (8.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DNA
Ginkgo Bioworks Holdings, Inc.
 276,817 $2,743,256
2 INCY
Incyte Corp
 21,815 $2,472,948
3 URGN
UroGen Pharma Ltd.
 37,000 $1,361,600
4 PRAX
Praxis Precision Medicines, Inc.
 3,846 $1,287,602
5 HALO
Halozyme Therapeutics, Inc.
 14,500 $1,134,915
6 REGN
Regeneron Pharmaceuticals, Inc.
This page 		1,614 $1,006,393
7 SPRY
ARS Pharmaceuticals, Inc.
 55,838 $447,262
8 BHVN
Biohaven Ltd.
 23,022 $342,567

All Filings in REGN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,006,393 1,614
2026-03-31 $1,175,185 1,521